» Articles » PMID: 23394479

Porphyrin-substituted H-NOX Proteins As High-relaxivity MRI Contrast Agents

Overview
Journal Inorg Chem
Specialty Chemistry
Date 2013 Feb 12
PMID 23394479
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Heme proteins are exquisitely tuned to carry out diverse biological functions while employing identical heme cofactors. Although heme protein properties are often altered through modification of the protein scaffold, protein function can be greatly expanded and diversified through replacement of the native heme with an unnatural porphyrin of interest. Thus, porphyrin substitution in proteins affords new opportunities to rationally tailor heme protein chemical properties for new biological applications. Here, a highly thermally stable Heme Nitric oxide/OXygen binding (H-NOX) protein is evaluated as a magnetic resonance imaging (MRI) contrast agent. T1 and T2 relaxivities measured for the H-NOX protein containing its native heme are compared to the protein substituted with unnatural manganese(II/III) and gadolinium(III) porphyrins. H-NOX proteins are found to provide unique porphyrin coordination environments and have enhanced relaxivities compared to commercial small-molecule agents. Porphyrin substitution is a promising strategy to encapsulate MRI-active metals in heme protein scaffolds for future imaging applications.

Citing Articles

Corrole-protein interactions in H-NOX and HasA.

Lemon C, Nissley A, Latorraca N, Wittenborn E, Marletta M RSC Chem Biol. 2022; 3(5):571-581.

PMID: 35656484 PMC: 9092467. DOI: 10.1039/d2cb00004k.


De novo biosynthesis of a nonnatural cobalt porphyrin cofactor in and incorporation into hemoproteins.

Perkins L, Weaver B, Buller A, Burstyn J Proc Natl Acad Sci U S A. 2021; 118(16).

PMID: 33850014 PMC: 8072207. DOI: 10.1073/pnas.2017625118.


Corrole-Substituted Fluorescent Heme Proteins.

Lemon C, Marletta M Inorg Chem. 2021; 60(4):2716-2729.

PMID: 33513009 PMC: 8714402. DOI: 10.1021/acs.inorgchem.0c03599.


The Red Color of Life Transformed - Synthetic Advances and Emerging Applications of Protoporphyrin IX in Chemical Biology.

Sitte E, Senge M European J Org Chem. 2020; 2020(22):3171-3191.

PMID: 32612451 PMC: 7319466. DOI: 10.1002/ejoc.202000074.


A novel thermophilic hemoprotein scaffold for rational design of biocatalysts.

Aggrey-Fynn J, Surmeli N J Biol Inorg Chem. 2018; 23(8):1295-1307.

PMID: 30209579 DOI: 10.1007/s00775-018-1615-z.


References
1.
Port M, Idee J, Medina C, Robic C, Sabatou M, Corot C . Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. Biometals. 2008; 21(4):469-90. DOI: 10.1007/s10534-008-9135-x. View

2.
Vojtechovsky J, Chu K, Berendzen J, Sweet R, Schlichting I . Crystal structures of myoglobin-ligand complexes at near-atomic resolution. Biophys J. 1999; 77(4):2153-74. PMC: 1300496. DOI: 10.1016/S0006-3495(99)77056-6. View

3.
Ananta J, Godin B, Sethi R, Moriggi L, Liu X, Serda R . Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nat Nanotechnol. 2010; 5(11):815-21. PMC: 2974055. DOI: 10.1038/nnano.2010.203. View

4.
Yang J, Yang J, Wei L, Zurkiya O, Yang W, Li S . Rational design of protein-based MRI contrast agents. J Am Chem Soc. 2008; 130(29):9260-7. PMC: 2692035. DOI: 10.1021/ja800736h. View

5.
Duncan A, Klemm P, Raymond K, Landry C . Silica microparticles as a solid support for gadolinium phosphonate magnetic resonance imaging contrast agents. J Am Chem Soc. 2012; 134(19):8046-9. PMC: 3403734. DOI: 10.1021/ja302183w. View